Department of Cell and Molecular Biology, University of Rhode Island, Kingston, RI 02881, USA.
BMC Microbiol. 2010 Jan 26;10:21. doi: 10.1186/1471-2180-10-21.
The bacterium Borrelia burgdorferi, the causative agent of Lyme disease, is a limited-genome organism that must obtain many of its biochemical building blocks, including N-acetylglucosamine (GlcNAc), from its tick or vertebrate host. GlcNAc can be imported into the cell as a monomer or dimer (chitobiose), and the annotation for several B. burgdorferi genes suggests that this organism may be able to degrade and utilize chitin, a polymer of GlcNAc. We investigated the ability of B. burgdorferi to utilize chitin in the absence of free GlcNAc, and we attempted to identify genes involved in the process. We also examined the role of RpoS, one of two alternative sigma factors present in B. burgdorferi, in the regulation of chitin utilization.
Using fluorescent chitinase substrates, we demonstrated an inherent chitinase activity in rabbit serum, a component of the B. burgdorferi growth medium (BSK-II). After inactivating this activity by boiling, we showed that wild-type cells can utilize chitotriose, chitohexose or coarse chitin flakes in the presence of boiled serum and in the absence of free GlcNAc. Further, we replaced the serum component of BSK-II with a lipid extract and still observed growth on chitin substrates without free GlcNAc. In an attempt to knockout B. burgdorferi chitinase activity, we generated mutations in two genes (bb0002 and bb0620) predicted to encode enzymes that could potentially cleave the beta-(1,4)-glycosidic linkages found in chitin. While these mutations had no effect on the ability to utilize chitin, a mutation in the gene encoding the chitobiose transporter (bbb04, chbC) did block utilization of chitin substrates by B. burgdorferi. Finally, we provide evidence that chitin utilization in an rpoS mutant is delayed compared to wild-type cells, indicating that RpoS may be involved in the regulation of chitin degradation by this organism.
The data collected in this study demonstrate that B. burgdorferi can utilize chitin as a source of GlcNAc in the absence of free GlcNAc, and suggest that chitin is cleaved into dimers before being imported across the cytoplasmic membrane via the chitobiose transporter. In addition, our data suggest that the enzyme(s) involved in chitin degradation are at least partially regulated by the alternative sigma factor RpoS.
导致莱姆病的细菌伯氏疏螺旋体是一种基因组有限的生物体,它必须从其蜱或脊椎动物宿主中获取许多生化构建块,包括 N-乙酰葡萄糖胺(GlcNAc)。GlcNAc 可以作为单体或二聚体(壳二糖)被导入细胞,并且伯氏疏螺旋体的几个基因的注释表明,该生物体可能能够降解和利用 GlcNAc 的聚合物几丁质。我们研究了伯氏疏螺旋体在没有游离 GlcNAc 的情况下利用几丁质的能力,并试图确定参与该过程的基因。我们还检查了 RpoS(伯氏疏螺旋体中存在的两种替代 sigma 因子之一)在几丁质利用中的调节作用。
使用荧光几丁质酶底物,我们证明了兔血清中存在固有几丁质酶活性,这是伯氏疏螺旋体生长培养基(BSK-II)的一个组成部分。通过煮沸使该活性失活后,我们表明野生型细胞可以在煮沸的血清存在下并且在没有游离 GlcNAc 的情况下利用壳三糖、壳六糖或粗几丁质薄片。此外,我们用脂质提取物代替 BSK-II 中的血清成分,仍然观察到在没有游离 GlcNAc 的情况下在几丁质底物上的生长。为了尝试敲除伯氏疏螺旋体几丁质酶活性,我们在两个基因(bb0002 和 bb0620)中生成突变,这些基因预测编码能够潜在切割几丁质中发现的β-(1,4)-糖苷键的酶。虽然这些突变对利用几丁质的能力没有影响,但编码壳二糖转运蛋白(bbb04,chbC)的基因的突变确实阻止了伯氏疏螺旋体利用几丁质底物。最后,我们提供的证据表明,rpoS 突变体中几丁质的利用比野生型细胞延迟,表明 RpoS 可能参与该生物体对几丁质降解的调节。
本研究收集的数据表明,伯氏疏螺旋体可以在没有游离 GlcNAc 的情况下将几丁质用作 GlcNAc 的来源,并表明几丁质在通过壳二糖转运蛋白穿过细胞质膜之前被切割成二聚体。此外,我们的数据表明,参与几丁质降解的酶至少部分受替代 sigma 因子 RpoS 调节。